Home     About Us     Medic-All     Bio B2B     Hot Topic     Expo     Login | Join Now     Search Button
Exhibitor List
Keyword Search

Safe Save Cell Medical Sciences & Technology Co.,Ltd

1. The sharing of the GBM clinical trial result of ADCTA, Autologous Dendritic Cell / Tumor Antigen
2. The introduction of an immunotherapy, ADCTA for the incurable fatal malignant diseases
3. The introduction of an advanced facility of manufacturing ADCTA abide by PIC/S GMP

Safe Save Medical Cell Science & Technology Co., Ltd is a startup global company, established by Wen-Kuang Yang M.D., Ph.D, in2011, having a subsidiary Self Safe Save in TN, USA, since 2017. HQ locates in Taiwan, entered Hsinchu Biomedical Science Park where the advanced facility was built abide by PIC/S GMP regulatory in 2015.

Prof. Yang has spent 50 years in US and TW to invent the cancer immunotherapy ADCTA, Autologous Dendritic Cell/Tumor Antigen for incurable fatal malignant diseases, the accomplishment of the GBM, Glioblastoma Multiforme clinical trials of phase I and II, held by Prof. Yang began in 2002 and 2005, those results surpassed significantly the conventional cancer treatments by still alive presently 15 years 2 patient, 10 years 2 patients and 8 years 1 patient, and the median of life 29.47 months over 15 months and 5 years OS, overall survival 17.20% over 0.00%. In 2018, SSC embarks the GBM clinical trial phase III, a multiple medical centre project to collaborate with 7 medical centre level hospitals, 12 seasoned clinical doctors and118 volunteer patients expected in Taiwan. It programmes to carry through by 2021 and time to Taiwan market by 2022 to benefit TW NHI expense and every kind of solid tumor patients with a safe, efficacy and affordable immunotherapy while having a quality life still.

As regards, the latest regulatory deployed by TFDA in the early of Sept. 2018 to approve the immunotherapy for selected cancer patients, SSC has been working closely with numbers of hospital and is hoped to be the pioneer to serve the cancer immunotherapy in Taiwan. SSC exhorts to be the benchmark globally after serving numbers of patients with expected successful outcomes.
Cooperation projects and needs
SSC devotes to Research, Development, Manufacture, Sell and partnership :
1. Clinical Trial Collaboration
2. Immunocyte Banking Saved
3. Cancer Immunotherapy
4. R&D Out-Licensing Partnership
5. ADCTA Turnkey Out-Licensing Partnership

Prof. Yang worked at Oak-Ridge Graduate School of Biomedical Science, USA from 1968 to 1993, well noted for his works on reversing transcription of tRNA by detaching numbers of translation gene codes, discovering the reverse transcription tRNA primer of oncogenic virus, elucidating the mechanism of how host gene Fv-1 restricts leukemia virus, DNA transfection technology and retrotransposomes. Meanwhile, he served as US NIH experimental virology review committee and later US NCI cancer biology and immunology research plan consultative review committee.

In 1993, when he was invited by Taiwan ACADAIMA SINICA as a distinguished researcher at the Institute of Biomedical Sciences while he established NHRI, National Health Research Institute as well as the clinical cancer laboratory for the collaboration between Taipei Veterans General Hospital and National Taiwan University Hospital at the same period.

Began in 1996 he has devoted himself on Dendritic Cells cancer immunotherapy study, since then he has been the leading authority of GBM immunotherapy in Asia in view of the significant outcomes of 2 clinical trials he held.

Safe Save Medical Cell Sciences & Technology established in 2011 aimed to be able to fast expand ADCTA to other cancers than GBM and other regions than Taiwan.

To benefit the people in the world is the original intention of SSC, based on the prior positive results, which are GBM is treated as the most malignant disease due to the complication of human brain is, the dendritic cells are well recognized to be the best potent APC, antigen-presenting cell and non-specific effects and the knowhow of ADCTA we are very optimistic in the near future SSC product roadmap will fast expand GBM clinical trials in Taiwan domestic, US and global wide to (metastatic) lung cancer, colon cancer, pancreatic cancer, prostate cancer, (recurrence) ovarian cancer, breast cancer, etc.

ADCTA increase greatly the OS, overall survival of the incurable fatal malignant disease, improve the patients’ life quality meanwhile and its Know How distinguishes itself along from the conventional dendritic cell immunotherapy or traditional cancer treatments.

We warmly welcome and value every potential business or collaboration opportunity.

Contact Information:
Sales & Marketing Division
Website: http://www.safesavecell.com.tw
Email: service@salesavecell.com.tw
Telephone: (03) 550-6696


BENCH , Fume Hood,

SciVision Biotech Inc.

Hyaluronic acid-based medical device:
1. Absorbable Adhesion Barrier
2. Synovial Fluid Supplement
3. Dermal Filler
4. Intravesical Instillation


SEDA combine material technology with physiological sensing technology, with the use of IoT (Internet of Things) and big data analysis, to develop a series of mattress systems and related products for residential LTC (Long-term Care) and smart medical applications.
The products cover sleep and pressure relief, bedsore (pressure ulcers) prevention, Fall Prevention Bed Alarms, Remote Care, Home Appliance Control, etc. Products have been used in a number of medical centers and teaching hospitals.
Cooperation projects and needs
Invite the operators of medical institutions and nursing supervisors to visit the exhibition booth, in-depth understanding of the "Smart Care mattress and system", "SEDA Anti-decubitus Mattress", "Decompression Pillow Series", "IoT Call & Light ", "WhizCarpet", reduce the workload of nursing staff and improve the quality of life of caregivers.

Senchangbiotech Corporation

Pesticide residue detector

Setsuro Tech Inc.

We are manufactures of genome editing mice and fertilized eggs. Our technology was developed by Takemoto et al., researchers at the Tokushima University and our company's CTO, obtained a patent for this technology. We deliver mice and fertilized eggs at a faster and economical rate than our competitors.Our method of genome editing- “Genome editing by electroporation of Cas9 protein”, abbreviated as the GEEP method, is different from other methods. GEEP method introduces a genome editing tool such as Cas9 protein and gRNA into a fertilized egg by electroporation. This is a high throughput method because it needs no sophisticated skills but only aligning fertilized eggs on electrodes. With the GEEP method, we can introduce genome editing tools into large amount of fertilized eggs with low damage.


Han Ma Far Infrared Therapy Unit, Han Ma Warmer, Han Ma Static electric tepid therapy blanket


Cell Processing Isolator



Introducing our Hospital

The Shin Kong Wu Ho-Su Memorial Hospital is a leading medical center with 42 specialty departments highly qualified for the diagnosis and treatment of a broad spectrum of diseases, and a total of 862 beds offers the best medical service to the community.

Founded in 1992, the Shin Kong Wu Ho-Su Memorial Hospital was approved by the National Health Ministry as a medical center after a rigorous accreditation process which further strengthened its commitment to provide the best health care services to all patients and to give back to the community as well.

To promote early diagnosis and disease prevention, the Department of Health Management was established in 2004. With collaboration of an outstanding medical team and application of state-of-the-art equipment such 256-slice computerized tomography (CT), positron emission tomography (PET/CT) and magnetic resonance imaging (MRI), the Health Management Center offers optimum one-stop, efficient health examination services for the public. The sophisticated high-end medical equipment renders possible the early screening of the top ranked three life-threatening illnesses - cancer, cerebrovascular diseases and cardiovascular diseases. Detailed and comprehensive explanation of the reports by the medical team is provided after the examinations.

The Shin Kong Hospital is particularly concerned about the needs of the international patients. The International Healthcare Center assists efficiently the patients before, during, and after their stay in Taiwan with the emphasis to provide them a pleasant and rewarding experience in our country.

Our Aim:
We consider the patients as the core of our medical care,
We provide quality service to feedback our society,
We develop professionalism in our staff members,
We pursue excellence through continuously innovative medical education and research programs.

Our Vision:
We are dedicated to maintaining professionalism, enthusiasm and spirit of service to achieve health, hope and happiness of our community and to strengthen our role as one of the most reliable medical centers.

Our Goals:
Service, Education, Research

Our Leading Specialties:
Health Management Center
PET Center
Cardiac CT Center
Brain MRI Center
Cosmetic Center
Cardiology & Cardiovascular Surgery
Neurology & Neurosurgery
Urology & Urologic Surgery
Radiation Therapy & Oncology
General Surgery
Robot-assisted surgery
Cooperation projects and needs

Shiteh Organic Pharmaceutical Co., Ltd.

Shiteh Organic Pharmaceutical Co., Ltd. is famous for OEM/ODM “Tiger Balm” “Day and Night Mouthwash”. There have "PIC/S GMP Pharmaceutical factory", "ISO 22000 and HACCP food factory" and "mouthwash factory". Shiteh has 54 years of experience in ointment production. We have own numerous awards and trophy, also obtained numerous patents and trademarks.

The projects of company's products has:
2.Health Care
3.Skin Care
4.Medical Materials

The project of exhibition have:
1.The probiotics ues for skin care:Series products of B.&N.+ MIN-I-CON.
2.Functional health food.
Cooperation projects and needs
We are seeking for:
1.agents, distributors.